Furthermore, a recent study demonstrated that O-GlcNAc glycosylation, which modifies intracellular proteins via O-GlcNAc transferase, inhibited PD-L1 degradation in cancer cells, thereby promoting immune evasion (37). The gene discussed is CD274; the disease is cancer.